Figure 2.
HMGB1 depletion in human cells increases psoralen ICL-induced mutagenesis. (A and B) Western blot to assess siRNA-mediated depletion of HMGB1 in U2OS (TP53 proficient) and HeLa (TP53 deficient) cells, respectively. Lanes 1 and 2, untreated control; lanes 3 and 4, mock-siRNA treated; lanes 5 and 6, HMGB1-siRNA treated. (C and D) Spontaneous (P) and ICL-induced (P-ICL) mutation frequencies in HMGB1-depleted U2OS and HeLa cells, respectively. Cells were transfected with pSupFG1 plasmid (P) or with TFO-directed psoralen-crosslinked pSupFG1 (P-ICL), as indicated under the bars. The results are an average of four independent experiments; error bars represent ± SD. P-values derived (from one-way ANOVA (Holm-Sidak method).